The RAs reprogrammed by melanoma cells expressed interleukin-23 to enhance the invasiveness of cancer cells, and cancer cell-derived matrix metalloproteinase-2 affected the status of astrocytes (48). The gene discussed is MMP2; the disease is cancer.